ENTA — Enanta Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Enanta Pharmaceuticals, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	387	244	249	370	248
Net Total Accounts Receivable
Net Total Receivables	23.5	60.8	49	39.6	38.6
Prepaid Expenses
Total Other Current Assets
Total Current Assets	437	319	312	423	300
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	15.6	10.7	29.7	34.7	73.3
Long Term Investments
Other Long Term Assets
Total Assets	486	439	375	462	377
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	24.2	36.2	29.8	62.8	57.5
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	30.6	39.4	54.1	246	248
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	456	399	321	217	129
Total Liabilities & Shareholders' Equity	486	439	375	462	377
Total Common Shares Outstanding